JP2006514093A5 - - Google Patents

Download PDF

Info

Publication number
JP2006514093A5
JP2006514093A5 JP2004570676A JP2004570676A JP2006514093A5 JP 2006514093 A5 JP2006514093 A5 JP 2006514093A5 JP 2004570676 A JP2004570676 A JP 2004570676A JP 2004570676 A JP2004570676 A JP 2004570676A JP 2006514093 A5 JP2006514093 A5 JP 2006514093A5
Authority
JP
Japan
Prior art keywords
ylmethyl
chloro
isoxazol
thiophen
imidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004570676A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006514093A (ja
JP4504820B2 (ja
Filing date
Publication date
Priority claimed from EP02027120A external-priority patent/EP1426364A1/en
Priority claimed from EP03011307A external-priority patent/EP1479674A1/en
Application filed filed Critical
Priority claimed from PCT/EP2003/012996 external-priority patent/WO2004050636A2/en
Publication of JP2006514093A publication Critical patent/JP2006514093A/ja
Publication of JP2006514093A5 publication Critical patent/JP2006514093A5/ja
Application granted granted Critical
Publication of JP4504820B2 publication Critical patent/JP4504820B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004570676A 2002-12-04 2003-11-20 Xa因子阻害剤としてのイミダゾール誘導体 Expired - Fee Related JP4504820B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02027120A EP1426364A1 (en) 2002-12-04 2002-12-04 Imidazole-derivatives as factor Xa inhibitors
EP03011307A EP1479674A1 (en) 2003-05-19 2003-05-19 Imidiazole-derivatives as factor xa inhibitors
PCT/EP2003/012996 WO2004050636A2 (en) 2002-12-04 2003-11-20 IMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS

Publications (3)

Publication Number Publication Date
JP2006514093A JP2006514093A (ja) 2006-04-27
JP2006514093A5 true JP2006514093A5 (enExample) 2006-11-09
JP4504820B2 JP4504820B2 (ja) 2010-07-14

Family

ID=32471891

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004570676A Expired - Fee Related JP4504820B2 (ja) 2002-12-04 2003-11-20 Xa因子阻害剤としてのイミダゾール誘導体

Country Status (12)

Country Link
EP (1) EP1569927B1 (enExample)
JP (1) JP4504820B2 (enExample)
AR (1) AR042261A1 (enExample)
AT (1) ATE401322T1 (enExample)
AU (1) AU2003285336B2 (enExample)
BR (1) BR0317003A (enExample)
CA (1) CA2507624A1 (enExample)
DE (1) DE60322254D1 (enExample)
MX (1) MXPA05005498A (enExample)
PE (1) PE20040700A1 (enExample)
TW (1) TW200504027A (enExample)
WO (1) WO2004050636A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI372050B (en) 2003-07-03 2012-09-11 Astex Therapeutics Ltd (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
JP4912314B2 (ja) 2004-10-26 2012-04-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 因子Xa化合物
EP1833819A1 (en) 2004-12-30 2007-09-19 Astex Therapeutics Limited Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases
US8399442B2 (en) 2005-12-30 2013-03-19 Astex Therapeutics Limited Pharmaceutical compounds
WO2008001115A2 (en) 2006-06-29 2008-01-03 Astex Therapeutics Limited Pharmaceutical combinations of 1-cyclopropyl-3- [3- (5-m0rphoolin-4-ylmethyl-1h-benzoimidazol-2-yl) -lh-1-pyrazol- 4-yl] -urea
WO2009105504A2 (en) 2008-02-21 2009-08-27 Schering Corporation Functionally selective alpha2c adrenoreceptor agonists
JP5996532B2 (ja) 2010-07-15 2016-09-21 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 有害生物防除剤としての新規複素環式化合物
CN114105881B (zh) * 2020-08-31 2024-01-26 沈阳海诺威医药科技有限公司 血小板聚集抑制剂及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020357A (en) * 1996-12-23 2000-02-01 Dupont Pharmaceuticals Company Nitrogen containing heteroaromatics as factor Xa inhibitors
EP1226123A1 (en) * 1999-11-03 2002-07-31 Du Pont Pharmaceuticals Company Cyano compounds as factor xa inhibitors
WO2002000651A2 (en) * 2000-06-27 2002-01-03 Bristol-Myers Squibb Pharma Company Factor xa inhibitors

Similar Documents

Publication Publication Date Title
JP2006511608A5 (enExample)
JP2006528940A5 (enExample)
CN101321525B (zh) 作为l-cpt1抑制剂的杂芳基取代的哌啶衍生物
US6982272B2 (en) Compounds useful as reversible inhibitors of cysteine proteases
JP5451633B2 (ja) トリアゾールオキサジアゾール誘導体
JP2006500348A5 (enExample)
JP2007517010A5 (enExample)
JP2006522037A5 (enExample)
JP2011507915A5 (enExample)
JP2011518836A5 (enExample)
JP2008503497A5 (enExample)
JP2006514093A5 (enExample)
JP2006522119A5 (enExample)
JP2007530570A5 (enExample)
ES2291913T3 (es) Piperidinas sustituidas como ligandos del receptor h3 de la histamina.
JP2006522771A5 (enExample)
JP2006525299A5 (enExample)
JP2010504323A5 (enExample)
US5977142A (en) Oxa-and thia-diazole muscarinic receptor antagonists
JP2016514709A5 (enExample)
JP2008513405A5 (enExample)
SG174876A1 (en) Piperidine derivatives as nk3 receptor antagonists
KR101599009B1 (ko) Cetp 억제 활성을 갖는 신규한 옥사졸리디논 유도체, 이의 제조방법 및 이를 포함하는 약학 조성물
ES2494065T3 (es) Derivados de pirrolidina
AU616708B2 (en) 4-heteropentacyclic-4-{n-(phenyl)amido}piperidine derivatives and pharmaceutical compositions and method employing such compounds